Association of FMO3 Variants and Trimethylamine N-Oxide Concentration, Disease Progression, and Mortality in CKD Patients

Associations of Trimethylamine N-Oxide With Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis

(2015) George A. Kaysen et al.   JOURNAL OF RENAL NUTRITION

Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis

(2014) Diana M. Shih et al.   JOURNAL OF LIPID RESEARCH

Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children: Summary findings from the Casa Pia Children's Amalgam Clinical Trial

(2014) James S. Woods et al.   NEUROTOXICOLOGY

The Flavin-Containing Monooxygenase 3 Gene and Essential Hypertension: The Joint Effect of Polymorphism E158K and Cigarette Smoking on Disease Susceptibility

(2014) Olga Bushueva et al.   International Journal of Hypertension

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Physical Activity and Change in Estimated GFR among Persons with CKD

(2013) C. Robinson-Cohen et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

A Prospective Study of Frailty in Nephrology-Referred Patients With CKD

(2012) Baback Roshanravan et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Chemical chaperones assist intracellular folding to buffer mutational variations

(2012) Anannya Bandyopadhyay et al.   Nature Chemical Biology

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

(2011) Zeneng Wang et al.   NATURE

The Association Between Serotonin Transporter Gene Promotor Polymorphism (5-HTTLPR) and Elemental Mercury Exposure on Mood and Behavior in Humans

(2010) Diana Echeverria et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

Flavin-containing monooxygenase 3 polymorphisms in 13 ethnic populations from Europe, East Asia and sub-Saharan Africa: frequency and linkage analysis

(2009) Mao Mao et al.   PHARMACOGENOMICS